wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38612128-16641D17-6646-4B31-848B-EBF53D2858EE
Q38612128-16641D17-6646-4B31-848B-EBF53D2858EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612128-16641D17-6646-4B31-848B-EBF53D2858EE
Advances in PARP inhibitors for the treatment of breast cancer.
P2860
Q38612128-16641D17-6646-4B31-848B-EBF53D2858EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612128-16641D17-6646-4B31-848B-EBF53D2858EE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8364e2cffe235c595f211120b4d87a77abfcb3a1
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105